Medicines for Europe (formerly EGA) represents the generic,
biosimilar and value added medicines industries across Europe. Its
vision is to provide sustainable access to high quality medicines,
based on 5 important pillars: patients, quality, value, sustainability
and partnership. Its members employ 160,000 people at over 350
manufacturing and R&D sites in Europe, and invest up to 17% of
their turnover inmedical innovation.
Medicines for Europe
50 rue d’Arlon
1000 Brussels
T : +32 (0)2 736 84 11
@medicinesforEU
Follow us on
EGA has become Medicines for Europe
PATIENTS
SUSTAINABILITY
VALUE
PARTNERSHIP
QUALITY
